IL107916A - 5-oxocycloalkatriazolo [1,5-c] pyrimidine-2(alkyl) carboxylic acid derivatives their preparation and their use as medicaments - Google Patents
5-oxocycloalkatriazolo [1,5-c] pyrimidine-2(alkyl) carboxylic acid derivatives their preparation and their use as medicamentsInfo
- Publication number
- IL107916A IL107916A IL10791693A IL10791693A IL107916A IL 107916 A IL107916 A IL 107916A IL 10791693 A IL10791693 A IL 10791693A IL 10791693 A IL10791693 A IL 10791693A IL 107916 A IL107916 A IL 107916A
- Authority
- IL
- Israel
- Prior art keywords
- formula
- acid
- alkyl
- pyrimidine
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4241562A DE4241562A1 (de) | 1992-12-10 | 1992-12-10 | Neue Triazolopyrimidone, ihre Herstellung und Verwendung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL107916A0 IL107916A0 (en) | 1994-04-12 |
| IL107916A true IL107916A (en) | 1996-09-12 |
Family
ID=6474848
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10791693A IL107916A (en) | 1992-12-10 | 1993-12-07 | 5-oxocycloalkatriazolo [1,5-c] pyrimidine-2(alkyl) carboxylic acid derivatives their preparation and their use as medicaments |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5654310A (no) |
| EP (1) | EP0673378B1 (no) |
| JP (1) | JP3490445B2 (no) |
| CN (1) | CN1098414A (no) |
| AT (1) | ATE150023T1 (no) |
| AU (1) | AU674371B2 (no) |
| CA (1) | CA2151243A1 (no) |
| CZ (1) | CZ144995A3 (no) |
| DE (2) | DE4241562A1 (no) |
| DK (1) | DK0673378T3 (no) |
| ES (1) | ES2099577T3 (no) |
| FI (1) | FI952856A (no) |
| GR (1) | GR3022980T3 (no) |
| HU (1) | HUT72300A (no) |
| IL (1) | IL107916A (no) |
| MX (1) | MX9307735A (no) |
| NO (1) | NO952291L (no) |
| NZ (1) | NZ258558A (no) |
| PL (1) | PL309329A1 (no) |
| RU (1) | RU95121818A (no) |
| WO (1) | WO1994013673A1 (no) |
| ZA (1) | ZA939228B (no) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4053600A (en) * | 1973-03-08 | 1977-10-11 | Sandoz, Inc. | Tricyclic 1,2,4-triazolo-quinazolines |
| US4128644A (en) * | 1977-07-29 | 1978-12-05 | E. R. Squibb & Sons, Inc. | Pyrazolo(1,5-c)quinazoline derivatives and related compounds |
| DE3146599A1 (de) * | 1981-11-25 | 1983-07-07 | Basf Ag, 6700 Ludwigshafen | Neue triazolochinazoline, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen |
| EP0217748B1 (en) * | 1985-09-30 | 1991-02-06 | Ciba-Geigy Ag | 2-Substituted-e-fused-[1,2,4,]triazolo-[1,5-c]pyrimidines pharmaceutical compositions and uses thereof |
| US5153196A (en) * | 1991-06-05 | 1992-10-06 | Eli Lilly And Company | Excitatory amino acid receptor antagonists and methods for the use thereof |
-
1992
- 1992-12-10 DE DE4241562A patent/DE4241562A1/de not_active Withdrawn
-
1993
- 1993-11-27 CZ CZ951449A patent/CZ144995A3/cs unknown
- 1993-11-27 EP EP94901898A patent/EP0673378B1/de not_active Expired - Lifetime
- 1993-11-27 HU HU9501692A patent/HUT72300A/hu unknown
- 1993-11-27 AU AU56285/94A patent/AU674371B2/en not_active Ceased
- 1993-11-27 NZ NZ258558A patent/NZ258558A/en unknown
- 1993-11-27 RU RU95121818/04A patent/RU95121818A/ru unknown
- 1993-11-27 ES ES94901898T patent/ES2099577T3/es not_active Expired - Lifetime
- 1993-11-27 DK DK94901898.0T patent/DK0673378T3/da active
- 1993-11-27 AT AT94901898T patent/ATE150023T1/de not_active IP Right Cessation
- 1993-11-27 WO PCT/EP1993/003332 patent/WO1994013673A1/de not_active Application Discontinuation
- 1993-11-27 DE DE59305812T patent/DE59305812D1/de not_active Expired - Fee Related
- 1993-11-27 PL PL93309329A patent/PL309329A1/xx unknown
- 1993-11-27 CA CA002151243A patent/CA2151243A1/en not_active Abandoned
- 1993-11-27 JP JP51372594A patent/JP3490445B2/ja not_active Expired - Fee Related
- 1993-12-07 IL IL10791693A patent/IL107916A/en not_active IP Right Cessation
- 1993-12-08 MX MX9307735A patent/MX9307735A/es unknown
- 1993-12-09 ZA ZA939228A patent/ZA939228B/xx unknown
- 1993-12-10 CN CN93121679A patent/CN1098414A/zh active Pending
-
1995
- 1995-06-01 US US08/446,838 patent/US5654310A/en not_active Expired - Fee Related
- 1995-06-09 NO NO952291A patent/NO952291L/no unknown
- 1995-06-09 FI FI952856A patent/FI952856A/fi not_active Application Discontinuation
-
1997
- 1997-03-31 GR GR970400656T patent/GR3022980T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL107916A0 (en) | 1994-04-12 |
| CA2151243A1 (en) | 1994-06-23 |
| WO1994013673A1 (de) | 1994-06-23 |
| EP0673378B1 (de) | 1997-03-12 |
| DK0673378T3 (da) | 1997-07-21 |
| JPH08504412A (ja) | 1996-05-14 |
| ES2099577T3 (es) | 1997-05-16 |
| EP0673378A1 (de) | 1995-09-27 |
| PL309329A1 (en) | 1995-10-02 |
| FI952856A0 (fi) | 1995-06-09 |
| FI952856A (fi) | 1995-06-09 |
| AU5628594A (en) | 1994-07-04 |
| MX9307735A (es) | 1994-06-30 |
| JP3490445B2 (ja) | 2004-01-26 |
| GR3022980T3 (en) | 1997-06-30 |
| DE59305812D1 (de) | 1997-04-17 |
| DE4241562A1 (de) | 1994-06-16 |
| NO952291D0 (no) | 1995-06-09 |
| HU9501692D0 (en) | 1995-08-28 |
| CZ144995A3 (en) | 1995-12-13 |
| HUT72300A (en) | 1996-04-29 |
| RU95121818A (ru) | 1997-06-10 |
| ZA939228B (en) | 1995-06-09 |
| CN1098414A (zh) | 1995-02-08 |
| AU674371B2 (en) | 1996-12-19 |
| US5654310A (en) | 1997-08-05 |
| ATE150023T1 (de) | 1997-03-15 |
| NZ258558A (en) | 1997-06-24 |
| NO952291L (no) | 1995-06-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102081272B1 (ko) | Janus 키나아제 억제제 | |
| KR102412035B1 (ko) | TGF-βRI 억제제인 벤조트리아졸에서 유도된 α,β-불포화 아미드계 화합물 | |
| CN103180319A (zh) | 氨基脲敏感性胺氧化酶抑制剂 | |
| AU652560B2 (en) | Quinoxaline compounds and their preparation and use | |
| TWI788424B (zh) | 受體抑制劑的并環類衍生物 | |
| CN1307178C (zh) | 用作保胎催产素受体拮抗剂的新型三环吡啶基苯并氮杂䓬羧酰胺及其衍生物 | |
| AU2001253538B2 (en) | Inhibitors of alpha l beta 2 mediated cell adhesion | |
| US4524146A (en) | Certain -2-heterocycle substituted pyrazoloquinolines | |
| AU685783B2 (en) | (1,2,4) triazolo (4,3-a) quinoxaline derivatives, their preparation and use | |
| EP0698024B1 (en) | [1,2,4]TRIAZOLO [4,3-a]QUINOXALINE COMPOUNDS, THEIR PREPARATION AND USE | |
| US5968946A (en) | Heterocyclic derivatives useful in treating central nervous system disorders | |
| NZ263552A (en) | 4,5-dihydro-4-oxoimidazolo[1,2-a]quinoxaline derivatives | |
| IL107916A (en) | 5-oxocycloalkatriazolo [1,5-c] pyrimidine-2(alkyl) carboxylic acid derivatives their preparation and their use as medicaments | |
| EP0511152A2 (en) | Quinoxaline compounds, their preparation and use | |
| EP1776366B1 (en) | Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors | |
| JP2001519350A (ja) | ナフト−イミダゾ［１，２−ａ］ピリジン誘導体、その製造及び中枢神経系障害の処置におけるその使用 | |
| US5631261A (en) | Triazoloquinazolines, their preparation and use | |
| US10669263B2 (en) | Substituted benzimidazole derivative as a modulator of TNF activity | |
| US6407109B1 (en) | Pyrrolyl tetrahydroquinoxalin diones, their production and use in the treatment of diseases | |
| NO162859B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive oksadiazolylimidazobenzodiazepinforbindelser. | |
| EP0500137B1 (en) | 1,2,4-Triazolo[1,5-a]pyrimidine derivatives, a process for preparing them as well as medicaments containing them and the use of them | |
| AU2003204221B2 (en) | Dipyridoimidazolderivatives useful in treating central nervous system disorders | |
| MXPA00009566A (en) | Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7, 8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives:crf1 specific ligands |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| RH | Patent void |